Lumida
/INMB
⌘K
INmune Bio Inc

INmune Bio Inc

INMB
$2.22USD-3.90%-0.09 today

MARKET CAP

61.6M

P/E (TTM)

FWD P/E

DAY RANGE

$2 – $2

52W RANGE

$1
$3
STATEMENT·Income statement
USD · GAAP
METRICFY 2021FY 2022FY 2023FY 2024FY 2025TREND
Sales, Adj.$181,000$374,000$155,000$14,000$50,000
YoY %+1545.5%+106.6%-58.6%-91.0%+257.1%
P / Sales909.0x321.6x1301.6x6652.8x772.4x
EV / Sales604.6x240.2x1192.0x5691.6x454.0x
Gross Profit, Adj.$181,000$374,000$155,000$14,000$50,000
YoY %+1545.5%+106.6%-58.6%-91.0%+257.1%
Margin %100.0%100.0%100.0%100.0%100.0%
EV / Gross Profit604.6x240.2x1192.0x5691.6x454.0x
EBITDA, Adj.$-30.3M$-26.0M$-29.7M$-42.6M$-30.8M
YoY %-148.1%+14.5%-14.6%-43.4%+27.8%
Margin %-16762.4%-6938.8%-19187.7%-304535.7%-61570.0%
EV / EBITDA-3.6x-3.5x-6.2x-1.9x-0.7x
EBIT$-30.3M$-26.0M$-29.7M$-42.6M$-30.9M
YoY %-148.1%+14.5%-14.6%-43.4%+27.6%
Margin %-16762.4%-6938.8%-19187.7%-304535.7%-61738.0%
EV / EBIT-3.6x-3.5x-6.2x-1.9x-0.7x
Net Income$-30.3M$-27.3M$-30.0M$-42.1M$-45.9M
YoY %-150.8%+10.0%-9.9%-40.2%-9.2%
Net Margin-16762.4%-7299.2%-19360.0%-300585.7%-91866.0%
EPS (GAAP)-$1.88-$1.52-$1.67-$2.11-$1.86
YoY %-86.1%+19.1%-9.9%-26.3%+11.8%